Registration number:
GKM MEDICAL LIMITED
for the Year Ended 31 January 2025
GKM MEDICAL LIMITED
Contents
|
Company Information |
|
|
Directors' Report |
|
|
Accountants' Report |
|
|
Profit and Loss Account |
|
|
Statement of Comprehensive Income |
|
|
Balance Sheet |
|
|
Statement of Changes in Equity |
|
|
Notes to the Unaudited Financial Statements |
|
|
Detailed Profit and Loss Account |
GKM MEDICAL LIMITED
Company Information
|
Directors |
Dr Gauruv Kumar Malhan Mrs Charlotte Elizabeth Malhan |
|
Registered office |
|
|
Accountants |
|
GKM MEDICAL LIMITED
Directors' Report for the Year Ended 31 January 2025
The directors present their report and the financial statements for the year ended 31 January 2025.
Directors of the company
The directors who held office during the year were as follows:
Principal activity
The principal activity of the company is Provision of Private Psychiatric Services.
Small companies provision statement
This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
Approved and authorised by the
|
......................................... |
Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
GKM MEDICAL LIMITED
for the Year Ended 31 January 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of GKM MEDICAL LIMITED for the year ended 31 January 2025 as set out on pages 4 to 13 from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.
This report is made solely to the Board of Directors of GKM MEDICAL LIMITED, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of GKM MEDICAL LIMITED and state those matters that we have agreed to state to the Board of Directors of GKM MEDICAL LIMITED, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than GKM MEDICAL LIMITED and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that GKM MEDICAL LIMITED has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of GKM MEDICAL LIMITED. You consider that GKM MEDICAL LIMITED is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of GKM MEDICAL LIMITED. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.
......................................
Chartered Accountants & Tax Advisors
265-269 Kingston Road
Wimbledon
London
SW19 3NW
GKM MEDICAL LIMITED
Profit and Loss Account for the Year Ended 31 January 2025
|
Note |
2025 |
2024 |
|
|
Turnover |
|
|
|
|
Gross profit |
|
|
|
|
Administrative expenses |
( |
( |
|
|
Operating profit |
698,027 |
663,111 |
|
|
Profit before tax |
|
|
|
|
Tax on profit |
( |
( |
|
|
Profit for the financial year |
|
|
The above results were derived from continuing operations.
The company has no recognised gains or losses for the year other than the results above.
GKM MEDICAL LIMITED
Statement of Comprehensive Income for the Year Ended 31 January 2025
|
2025 |
2024 |
|
|
Profit for the year |
|
|
|
Total comprehensive income for the year |
|
|
GKM MEDICAL LIMITED
(Registration number: 10557066)
Balance Sheet as at 31 January 2025
|
Note |
2025 |
2024 |
|
|
Fixed assets |
|||
|
Tangible assets |
|
|
|
|
Other financial assets |
280,000 |
50,000 |
|
|
|
|
||
|
Current assets |
|||
|
Debtors |
|
|
|
|
Cash at bank and in hand |
|
|
|
|
|
|
||
|
Creditors: Amounts falling due within one year |
( |
( |
|
|
Net current assets |
|
|
|
|
Total assets less current liabilities |
|
|
|
|
Provisions for liabilities |
( |
- |
|
|
Net assets |
|
|
|
|
Capital and reserves |
|||
|
Called up share capital |
2 |
2 |
|
|
Retained earnings |
1,375,810 |
1,117,394 |
|
|
Shareholders' funds |
1,375,812 |
1,117,396 |
For the financial year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
|
• |
|
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.
Approved and authorised by the
|
......................................... |
GKM MEDICAL LIMITED
Statement of Changes in Equity for the Year Ended 31 January 2025
|
Share capital |
Retained earnings |
Total |
|
|
At 1 February 2024 |
|
|
|
|
Profit for the year |
- |
|
|
|
Dividends |
- |
( |
( |
|
At 31 January 2025 |
|
|
|
|
Share capital |
Retained earnings |
Total |
|
|
At 1 February 2023 |
|
|
|
|
Profit for the year |
- |
|
|
|
Dividends |
- |
( |
( |
|
At 31 January 2024 |
2 |
1,117,394 |
1,117,396 |
GKM MEDICAL LIMITED
Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025
|
General information |
The company is a private company limited by share capital, incorporated in England & Wales.
The address of its registered office is:
These financial statements were authorised for issue by the
|
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Revenue recognition
Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.
Tax
The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.
GKM MEDICAL LIMITED
Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025
Tangible assets
Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.
Depreciation
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:
|
Asset class |
Depreciation method and rate |
|
Furniture,Fittings |
WDV 25% |
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
Trade debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.
Trade creditors
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.
Borrowings
Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.
GKM MEDICAL LIMITED
Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025
Provisions
Provisions are recognised when the company has an obligation at the reporting date as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.
Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.
Dividends
Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.
|
Staff numbers |
The average number of persons employed by the company (including directors) during the year, was
|
Profit before tax |
Arrived at after charging/(crediting)
|
2025 |
2024 |
|
|
Depreciation expense |
|
|
GKM MEDICAL LIMITED
Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025
|
Tangible assets |
|
Furniture, fittings and equipment |
Total |
|
|
Cost or valuation |
||
|
At 1 February 2024 |
|
|
|
Additions |
|
|
|
Disposals |
( |
( |
|
At 31 January 2025 |
|
|
|
Depreciation |
||
|
At 1 February 2024 |
|
|
|
Charge for the year |
|
|
|
Eliminated on disposal |
( |
( |
|
At 31 January 2025 |
|
|
|
Carrying amount |
||
|
At 31 January 2025 |
|
|
|
At 31 January 2024 |
|
|
|
Other financial assets (current and non-current) |
|
Financial assets at fair value through profit and loss |
Financial assets at cost less impairment |
Total |
|
|
Non-current financial assets |
|||
|
Cost or valuation |
|||
|
Fair value adjustments |
80,000 |
- |
80,000 |
|
Additions |
- |
200,000 |
200,000 |
|
At 31 January 2025 |
80,000 |
200,000 |
280,000 |
|
Impairment |
|||
|
Carrying amount |
|||
|
At 31 January 2025 |
|
|
280,000 |
GKM MEDICAL LIMITED
Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025
|
Debtors |
|
Current |
Note |
2025 |
2024 |
|
Trade debtors |
|
|
|
|
Amounts owed by related parties |
|
|
|
|
Prepayments |
- |
|
|
|
Other debtors |
|
|
|
|
|
|
GKM MEDICAL LIMITED
Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025
|
Creditors |
Creditors: amounts falling due within one year
|
Note |
2025 |
2024 |
|
|
Due within one year |
|||
|
Loans and borrowings |
|
- |
|
|
Trade creditors |
|
|
|
|
Taxation and social security |
|
|
|
|
Accruals and deferred income |
|
|
|
|
Other creditors |
|
- |
|
|
|
|
|
Share capital |
Allotted, called up and fully paid shares
|
2025 |
2024 |
|||
|
No. |
£ |
No. |
£ |
|
|
|
|
50 |
|
50 |
|
|
|
50 |
|
50 |
|
|
|
|
|
|
|
Loans and borrowings |
Current loans and borrowings
|
2025 |
2024 |
|
|
Bank overdrafts |
|
- |
|
Dividends |
Interim dividends paid
|
2025 |
2024 |
|||
|
Interim dividend of £Nil per each |
|
|
||
|
Interim dividend of £Nil per each |
|
|
||
|
|
|
GKM MEDICAL LIMITED
Detailed Profit and Loss Account for the Year Ended 31 January 2025
|
2025 |
2024 |
|
Turnover |
||
|
Rendering of services, UK |
916,071 |
828,474 |
|
Employment costs |
||
|
Directors pensions (Other) |
32,000 |
24,000 |
|
Private health insurance |
3,403 |
3,402 |
|
Staff training |
1,930 |
2,561 |
|
37,333 |
29,963 |
|
Establishment costs |
||
|
Rent |
9,375 |
11,723 |
|
Use of home as office |
312 |
2,400 |
|
9,687 |
14,123 |
|
General administrative expenses |
||
|
Telephone and fax |
2,462 |
2,582 |
|
Computer software and maintenance costs |
3,086 |
2,520 |
|
Printing, postage and stationery |
227 |
1,119 |
|
Trade subscriptions |
4,939 |
723 |
|
Sundry expenses |
970 |
32 |
|
Travel and subsistence |
11,963 |
11,023 |
|
Hotel accommodation |
- |
5,142 |
|
Staff entertaining (allowable for tax) |
1,635 |
2,005 |
|
Customer entertaining (disallowable for tax) |
2,345 |
3,083 |
|
Accountancy fees |
5,966 |
5,162 |
|
Consultancy fees |
88,542 |
72,801 |
|
Professional indemnity insurance |
6,914 |
6,925 |
|
Legal and professional fees |
2,521 |
2,284 |
|
Bad debts written off |
29,345 |
225 |
|
Interest on Corporation Tax |
5,968 |
2,058 |
|
166,883 |
117,684 |
|
Finance charges |
||
|
Bank charges |
21 |
157 |
|
Depreciation costs |
||
|
Depreciation of office equipment (owned) |
4,120 |
3,436 |